NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes.
about
Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucineThalidomide in the treatment of cancer cachexia: a randomised placebo controlled trialTumor necrosis factor-alpha and muscle wasting: a cellular perspectiveEffects of dietary curcumin or N-acetylcysteine on NF-kappaB activity and contractile performance in ambulatory and unloaded murine soleusProlonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired WeaknessExpression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer CachexiaThe central role of hypothalamic inflammation in the acute illness response and cachexiaLongevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intakeModulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κBMaintenance of muscle mass is not dependent on the calcineurin-NFAT pathwayChanges in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restrictionPalmitate-activated macrophages confer insulin resistance to muscle cells by a mechanism involving protein kinase C θ and εNF-kappaB mediates the transcription of mouse calsarcin-1 gene, but not calsarcin-2, in C2C12 cellsModels of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.Meta-analysis of expression signatures of muscle atrophy: gene interaction networks in early and late stages.Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in miceInflammation based regulation of cancer cachexiaA new role for sterol regulatory element binding protein 1 transcription factors in the regulation of muscle mass and muscle cell differentiation.Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans.IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation.The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in miceLong-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac functionTNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokineTumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathwaySkeletal muscle changes after hemiparetic stroke and potential beneficial effects of exercise intervention strategies.The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.Nitric Oxide does not mediate Atrogin-1/MAFbx upregulation by inflammatory mediators.Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients.Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regenerationTargeting aldose reductase for the treatment of cancerDecreased NADPH oxidase expression and antioxidant activity in cachectic skeletal muscle.Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia.Alternative splicing factor ASF/SF2 is down regulated in inflamed muscle.Skeletal muscle atrophy is attenuated in tumor-bearing mice under chemotherapy by treatment with fish oil and selenium.
P2860
Q24633679-5C70170D-201E-4E31-90D1-BD16028BEF99Q24685678-DEF47C96-A1CE-4271-BFE6-FA53BE66EE05Q24806646-654DA5EB-E565-420F-AA19-27B32F508F00Q24814124-4DBBD74D-7AF6-4000-AACF-1FF46DC8C37EQ26741099-D1EAFBA3-BC2C-46D1-86B9-9C03FE28FC87Q27334169-3C2779AE-4656-4385-9470-938222505577Q28080648-FEAEED00-FD34-4776-9239-779B7A157236Q28083422-35872465-E0F7-413C-A1DF-58C608D5449BQ28389686-6A074E1B-3037-4EA1-93D8-3E142241ECF9Q28568904-6E1FC188-524A-4162-9BAB-025F0C633A98Q28569873-6659A7DD-6F99-48BE-840C-38C544715FE7Q28743444-8F0DEB34-3E82-4A46-8AEC-54B90305C3E9Q33277123-995EE3FC-8FF4-41E2-86B9-21234783FE96Q33349016-878E76A2-EB2A-4266-A36E-1162ADE5624AQ33395836-D54CAA53-373B-4E5B-9020-AB332692D887Q33526358-7B427E3C-4823-4DC7-A2E0-1EB30BAA4E35Q33615916-42922938-8CFA-4DE2-98AD-F869491E3AA7Q33648820-F4EA672A-F5D2-489C-A291-445FDB8FEB57Q33654592-E82BBB8B-7EA2-43E4-96F2-0ECED14EBFEAQ33799514-451F3316-969D-4261-A8CA-81D2AC69B3CEQ33901722-EDBD9FBF-1147-4D63-A073-E9D23AA9941FQ33985083-C2BA5179-ED05-4129-AF4A-030B4C561581Q33988273-C5DAF72C-51E6-4D73-BDA0-E3D47FC8C443Q33993411-A008E9D8-C766-4628-B592-712105F99B80Q34005353-6C31BF89-84C8-4B23-86B2-1177F846C68FQ34132318-507441AF-EE38-4294-9A34-BA17DA682662Q34132341-EA512ACB-AB54-423C-BE7E-D72440A7561FQ34300962-F15F9950-9B8C-4514-85DE-4882E0FF13D5Q34483183-A109F370-2993-4277-A940-54A38D4675B9Q34660312-5F8ED0A8-B7C4-4CEA-AFAA-3C07A96953F2Q34697114-C0910128-AFDE-4D63-88D0-5B6C59F8640EQ34997519-B8EB20D9-0B52-4A6F-97DB-667557E3B7A2Q34997536-4920C1D8-F609-4FE6-B3CE-9A7358B1A190Q35111740-55966A7B-B0BD-4310-BB16-933CDFFE5DF5Q35112511-4A119744-748C-474C-8E15-38CE0239FC50Q35125587-0FFB5E36-418E-40B4-A8DE-28D7F2CE6998Q35223974-3ECC9403-BDCF-4534-BA1F-C92A363410ADQ35254722-2F76AC5C-2613-4A7E-B57D-932460CEDE84Q35770262-DD4710F8-C8CE-43F6-9BC3-6938880060A0Q35781409-0415B274-A719-49CC-9CAA-8BB7D103EEC0
P2860
NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
NF-kappaB mediates the protein ...... ated skeletal muscle myotubes.
@en
type
label
NF-kappaB mediates the protein ...... ated skeletal muscle myotubes.
@en
prefLabel
NF-kappaB mediates the protein ...... ated skeletal muscle myotubes.
@en
P1476
NF-kappaB mediates the protein ...... ated skeletal muscle myotubes.
@en
P304
P356
10.1152/AJPREGU.2000.279.4.R1165
P577
2000-10-01T00:00:00Z